Stephane Ciblat

9 Patents

• US124862762025

  5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine Derivatives and Related Compounds as Trk Kinase Inhibitors for Treating Cancer

  Pyramid Biosciences, Inc.

  0 cites
• US123123392025

  Polo Like Kinase 4 Inhibitors

  ORIC PHARMACEUTICALS, Inc.

  0 cites
• US122408692025

  Inhibitors of Cyclin-dependent Kinase 7 (CDK7)

  Syros Pharmaceuticals, Inc.

  0 cites
• US121509342024

  Methods of Using Substituted Pyrazole and Pyrazole Compounds and for Treatment of Hyperproliferative Diseases

  Bantam Pharmaceutical, LLC

  0 cites
• US119185922024

  Inhibitors of Cyclin Dependent Kinase 7 (CDK7)

  Syros Pharmaceuticals, Inc.

  0 cites
• US118589152024

  Polo Like Kinase 4 Inhibitors

  ORIC PHARMACEUTICALS, Inc.

  0 cites
• US117534182023

  Compounds for the Modulation of Myc Activity

  Syros Pharmaceuticals, Inc.

  0 cites
• US117390962023

  5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo [1,5-a]pyrimidine Derivatives and Related Compounds as Trk Kinase Inhibitors for Treating Cancer

  Pyramid Biosciences, Inc.

  0 cites
• US116025262023

  Substituted Pyrazole and Pyrrole Compounds and Methods for Using Them for Inhibition of Initiation of Translation and Treatment of Diseases and Disorders Relating Thereto

  Bantam Pharmaceutical, LLC

  0 cites